Ceramide and insulin resistance: How should the issue be approached?

Diabetes

Volumn 61, Issue 12, 2012, Pages 3081-3083

  Górski, Jan ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; INSULIN; SPHINGOLIPID; SPHINGOMYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CATABOLISM; CONTROLLED STUDY; DEACYLATION; DIABETES MELLITUS; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

ANIMALS; CERAMIDES; DIET, HIGH-FAT; INSULIN RESISTANCE; MUSCLE, SKELETAL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EID: 84870386833     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1157     Document Type: Note

References (20)

1. Lipina C, Hundal HS. Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance. Diabetologia 2011;54:1596-1607
2. Straczkowski M, Kowalska I. The role of skeletal muscle sphingolipids in the development of insulin resistance. Rev Diabet Stud 2008;5:13-24
3. Summers SA. Sphingolipids and insulin resistance: the five Ws. Curr Opin Lipidol 2010;21:128-135
4. Dobrzyń A, Górski J. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise. Am J Physiol Endocrinol Metab 2002;282:E277-E285 (Pubitemid 34654797)
5. Straczkowski M, Kowalska I, Nikolajuk A, et al. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 2004;53:1215-1221 (Pubitemid 38569006)
6. Gault CR, Obeid LM, Hannun YA. An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med Biol 2010;688:1-23
7. Riboni L, Viani P, Bassi R, Prinetti A, Tettamanti G. The role of sphingolipids in the process of signal transduction. Prog Lipid Res 1997;36:153-195 (Pubitemid 28045910)
8. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006;45:42-72 (Pubitemid 43170804)
9. Schmitz-Peiffer C. Targeting ceramide synthesis to reverse insulin resistance. Diabetes 2010;59:2351-2353
10. Ussher JR, Koves TR, Cadete VJJ, et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 2010;59:2453-2464
11. Chavez JA, Holland WL, Bär J, Sandhoff K, Summers SA. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem 2005;280:20148-20153 (Pubitemid 41379546)
12. Chavez JA, Knotts TA, Wang LP, et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003;278:10297-10303 (Pubitemid 36800291)
13. Mitsutake S, Date T, Yokota H, Sugiura M, Kohama T, Igarashi Y. Ceramide kinase deficiency improves diet-induced obesity and insulin resistance. FEBS Lett 2012;586:1300-1305
14. Langeveld M, Aerts JMFG. Glycosphingolipids and insulin resistance. Prog Lipid Res 2009;48:196-205
15. Bruce CR, Risis S, Babb JR, et al. Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice. Diabetes 2012;61:3148-3155
16. Li CM, Hong SB, Kopal G, et al. Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase. Genomics 1998;50:267-274 (Pubitemid 28303521)
17. Błachnio-Zabielska A, Baranowski M, Zabielski P, Górski J. Effect of exercise duration on the key pathways of ceramide metabolism in rat skeletal muscles. J Cell Biochem 2008;105:776-784
18. Błachnio-Zabielska A, Baranowski M, Zabielski P, Górski J. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle. J Cell Physiol 2010;225:786-791
19. Bartke N, Hannun YA. Bioactive sphingolipids: metabolism and function. J Lipid Res 2009;50(Suppl.):S91-S96
20. Takabe K, Paugh SW, Milstien S, Spiegel S. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 2008;60:181-195 (Pubitemid 351962008)